Patient Safety Key as NACDS and APhA Oppose Prescription Drug Importation Emphasize commitment to safer, more effective strategies to reduce drug prices and increase access to prescription medications

By |2019-02-12T17:13:56-05:00Jan-18-19|Categories: Press Release|Tags: , |

NACDS and the American Pharmacists Association (APhA) expressed concerns about the risks to patient health and the security of the prescription drug supply chain in opposing legislation that would allow for personal and commercial importation of prescription drugs outside of the Food and Drug Administration’s (FDA) oversight.

At the White House’s Invitation, NACDS Participates in Bill Signing Ceremony for “Gag Clause” Prohibition NACDS applauds Trump Administration’s focus on reducing patients’ out-of-pocket prescription drug costs, and Congressional sponsors’ effectiveness in advancing legislation

By |2018-10-10T14:30:40-05:00Oct-10-18|Categories: Press Release|Tags: , , |

NACDS applauded the Trump Administration’s focus on reducing patients’ out-of-pocket drug costs, and Congressional sponsors’ effectiveness in advancing the "gag clause" ban. NACDS noted that pharmacy is a long-standing and trusted partner in helping patients achieve prescription-drug affordability – which is essential for health and wellness.

Op-Ed by NACDS, Johns Hopkins Center for Health Security Describes Pharmacy’s Role in Preventing Antibiotic Resistance Morning Consult publishes study’s findings on public health priorities

By |2017-11-17T08:08:22-05:00Nov-17-17|Categories: Press Release|Tags: , , , |

Morning Consult published an op-ed co-authored by Steven C. Anderson, IOM, CAE, president and CEO of NACDS, and Gigi Kwik Gronvall, PhD., senior associate at the Johns Hopkins Center for Health Security.